FDA
approval
· 2022-05-05
FDA Approved: RANOLAZINE — Original Application (Camber Pharmaceuticals, Inc.)
Summary
FDA approves Camber Pharmaceuticals' original ANDA for ranolazine, allowing a generic version of the antianginal medication.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for RANOLAZINE (RANOLAZINE)